$EUDA News

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

EUDA Health Collaborates With GO POSB Organoids And Shenzhen Innovation To Develop Next‑Gen Off‑the‑Shelf iPSC‑Based NK Cell Therapies For Wellness And Oncology Across Asia

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Health Launches Regenixé iPSC-derived Skin Stem Cell Secretome Mask; Regains Nasdaq Listing Compliance

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

EUDA Health Holdings Receives Nasdaq Listing Notice

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Reported Earlier: EUDA Health Announces 1-For-20 Reverse Stock Split Effective March 23, 2026

EUDA Announces Reverse Stock Split of its Ordinary Shares

EUDA Health price target lowered to $2.75 from $6 at Greenridge

Euda Health shares are trading lower after Greenridge Global lowered its price target on the stock from $6 to $2.75.

12 Health Care Stocks Moving In Monday's Intraday Session

Greenridge Global Maintains Buy on EUDA Health Holdings, Lowers Price Target to $2.75

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant